Rachel G. Liao

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <i>ERBB2</i>

Heidi Greulich, Bethany Kaplan, Philipp Mertins et al. · Proceedings of the National Academy of Sciences · 2012 · 264 citations · Full text

Systems Biology, Signal Transduction, Engineering +14

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Melissa Cline, Rachel G. Liao, Michael T. Parsons et al. · PLoS Genetics · 2018 · 205 citations · Full text

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Li Tan, Jun Wang, Junko Tanizaki et al. · Proceedings of the National Academy of Sciences · 2014 · 175 citations · Full text

Covalent Inhibitors, Fgfr Inhibitors, Human Fgf Receptors +18

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha et al. · Cancer Research · 2013 · 167 citations · Full text

Family Members, Fgfr Inhibitors, Medicine +14

Facilitating a culture of responsible and effective sharing of cancer genome data

Lillian L. Siu, Mark Lawler, David Haussler et al. · Nature Medicine · 2016 · 92 citations

Systems Biology, Health Informatics, Functional Genomics +11